Back
Roper Technologies 10K Form
Buy
62
ROP
Roper Technologies
Last Price:
561.82
Seasonality Move:
4.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | ROP/Roper Technologies Quarterly |
2024-02-22 | 10K | ROP/Roper Technologies Annual |
2023-11-02 | 10Q | ROP/Roper Technologies Quarterly |
2023-08-03 | 10Q | ROP/Roper Technologies Quarterly |
2023-05-03 | 10Q | ROP/Roper Technologies Quarterly |
2023-02-27 | 10K | ROP/Roper Technologies Annual |
Receive ROP News And Ratings
See the #1 stock for the next 7 days that we like better than ROP
ROP Financial Statistics
Sales & Book Value
Annual Sales: | $6.18B |
---|---|
Cash Flow: | $719.2M |
Price / Cash Flow: | 27.63 |
Annual Sales: | $172.72 |
Price / Book: | 3.23 |
Profitability
EPS (TTM): | 13.67000 |
---|---|
Net Income (TTM): | $1.48B |
Gross Margin: | $4.31B |
Return on Equity: | 8.3% |
Return on Assets: | 5% |
Roper Technologies Earnings Forecast
Key Roper Technologies Financial Ratios
- The Gross Profit Margin over the past 33 years for ROP is 69.72%.
- The Selling, General & Administrative Expenses for ROP have been equal to 41.47% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 11.90% of Operating Income.
- The Net Earning history of ROP is 22.41% of Total Revenues.
- Per Share Earnings over the last 33 years have been positive in 22 years.
Roper Technologies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | ROP |
CUSIP: | 776696 |
Website: | ropertech.com |
Debt
Debt-to-Equity Ratio: | 0.45 |
---|---|
Current Ratio: | 0.48 |
Quick Ratio: | 0.38 |
Price-to-Earnings
Trailing P/E Ratio: | 43.28 |
---|---|
Forward P/E Ratio: | 27.78 |
ROP Technical Analysis vs Fundamental Analysis
Buy
62
Roper Technologies (ROP)
is a Buy
Is Roper Technologies a Buy or a Sell?
-
Roper Technologies stock is rated a Buy
The current Roper Technologies [ROP] share price is $557.94. The Score for ROP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.